Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor

American Journal of Kidney Diseases

Volumn 56, Issue 1, 2010, Pages 168-174

  Regolisti, Giuseppe ^a   Cabassi, Aderville ^a   Parenti, Elisabetta ^a   Maggiore, Umberto ^a   Fiaccadori, Enrico ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Hypomagnesemia; proton pump inhibitors

Indexed keywords

CANDESARTAN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LANSOPRAZOLE; MAGNESIUM; MAGNESIUM SULFATE; METFORMIN; PANTOPRAZOLE; PYROGLUTAMATE MAGNESIUM; RANITIDINE; STREPTOMYCIN;

AGED; ANOREXIA; ARTICLE; ATAXIA; BARRETT ESOPHAGUS; CASE REPORT; CONFUSION; DELIRIUM; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; ESSENTIAL HYPERTENSION; FALLING; GLUCOSE BLOOD LEVEL; HALLUCINATION; HEARING LOSS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; LONG TERM CARE; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; URINE RETENTION;

AGED; HUMANS; MAGNESIUM DEFICIENCY; MALE; PROTON PUMP INHIBITORS; TIME FACTORS;

EID: 77953683534     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.03.013     Document Type: Article

References (44)

1. Topf J.M., and Murray P.T. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 4 2 (2003) 195-206
2. Tong G.M., and Rude R.K. Magnesium deficiency in critical illness. J Intensive Care Med 20 1 (2005) 3-17
3. Wong E.T., Rude R.K., Singer F.R., et al. A high prevalence of hypomagnesemia in hospitalized patients. Am J Clin Pathol 79 3 (1983) 348-352
4. Desai T.K., Carlson R.W., Geheb M.A., et al. Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 84 2 (1988) 209-214
5. Chernow B., Bamberger F., Stoiko M., et al. Hypomagnesemia in patients in postoperative intensive care. Chest 95 2 (1989) 391-397
6. Fiaccadori E., Del Canale S., Coffrini E., et al. Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med 16 8 (1988) 751-760
7. Kraft M.D., Btaiche I.F., and Sachs G.S. Review of the refeeding syndrome. Nutr Clin Pract 20 6 (2005) 625-633
8. Subbiah V., and Tayek J.A. Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med 137 3 (2002) 219
9. Epstein M., McGrath S., and Law F. Proton pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 355 17 (2006) 1834-1836
10. Cundy T., and Dissanayake A. Severe hypomagnaesemia in long-term users of proton-pump inhibitors. Clin Endocrinol 69 2 (2008) 338-341
11. Shabajee N., Lamb E.J., Sturgess I., and Sumathipala R.W. Omeprazole and refractory hypomagnesemia. BMJ 337 (2008) a425 10.1136/bmj.39505.738981.BE
12. Kuipers M.T., Thang H.D., and Arntzhenius A.B. Hypomagnesemia due to use of proton pump inhibitors-a review. Neth J Med 67 5 (2009) 169-172
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 6 (1999) 461-470
14. Rude R.K., Bethune J.E., and Singer F.R. Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypoparathyroid man. J Clin Endocrinol Metab 51 6 (1980) 1425-1431
15. Noronha J.L., and Matuschak G.M. Magnesium in critical illness: metabolism, assessment and treatment. Intensive Care Med 28 6 (2002) 667-679
16. Agus Z.S. Hypomagnesemia. J Am Soc Nephrol 10 7 (1999) 1616-1622
17. Alexander R.T., Hoenderop J.G.J., and Bindels R.J.M. Molecular mechanisms of magnesium homeostasis: insights from human disease. J Am Soc Nephrol 19 8 (2008) 1451-1458
18. Quamme G.A. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 24 2 (2008) 230-235
19. Gunzel D., and Yu A.S.L. Function and regulation of claudins in the thick ascending limb of Henle. Eur J Physiol 458 1 (2009) 77-88
20. Dai L.J., Ritchie G., Kerstan D., Kang H.S., Cole D.E.C., and Quamme G.A. Magnesium transport in the distal convoluted tubule. Physiol Rev 81 1 (2001) 51-84
21. Cao G., Hoenderop J.G.J., and Bindels R.J.M. Insights into the molecular regulation of the epithelial magnesium channel TRPM6. Curr Opin Nephrol Hypertens 17 4 (2008) 373-378
22. Rondon L.J., Groenestege W.M.T., Rayssiguier Y., and Mazur A. Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine. Am J Physiol Regul Comp Physiol 294 6 (2008) R2001-R2007
23. Pham P.C., Pham P.M., Pham S.V., Miller J.M., and Pham P.T. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2 2 (2007) 366-373
24. Weber S., Hoffmann K., Jeck N., et al. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8 6 (2000) 414-422
25. Konrad M., Schaller A., Seelow D., et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79 5 (2006) 949-957
26. Schlingmann K.P., Weber S., Peters M., et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31 2 (2002) 166-170
27. Meij I.C., Koenderink J.B., van Bokhoven H., et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K(+)-ATPase gamma-subunit. Nat Genet 26 3 (2000) 265-266
28. Groenestege W.M., Thebault S., van der Wijst J., et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 117 8 (2007) 2260-2267
29. Simon D.B., Karet F.E., Hamdan J.M., Di Pietro A., Sanjad S.A., and Lifton R.P. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13 2 (1996) 183-188
30. Peters M., Jeck N., Reinalter S., et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112 3 (2002) 183-190
31. Simon D.B., Bindra R.S., Mansfield T.A., et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17 2 (1997) 171-178
32. Birkenhager R., Otto E., Schurmann M.J., et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29 3 (2001) 310-314
33. Schlingmann K.P., Konrad M., Jeck N., et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 350 13 (2004) 1314-1319
34. Simon D.B., Nelson-Williams C., Bia M.J., et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12 1 (1996) 24-30
35. Watanabe S., Fukumoto S., Chang H., et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360 9334 (2002) 692-694
36. Scholl U.I., Choi M., Liu T., et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A 106 14 (2009) 5842-5847
37. Bockenhauer D., Feather S., Stanescu H.C., et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 360 19 (2009) 1960-1970
38. Glaudemans B., van derWijst J., Scola R.H., et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest 119 4 (2009) 936-942
39. Wilson F.H., Hariri A., Farhi A., et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306 5699 (2004) 1190-1194
40. Rude R.K., Oldham S.B., and Singer F.R. Functional hypoparathyroidism and parathyroid hormone and organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5 3 (1976) 209-224
41. Estep H., Shaw W.A., Watlington C., Hobe R., Holland W., and Tucker S.G. Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J Clin Endocrinol Metab 29 6 (1969) 842-848
42. Jeppesen P.B., Staun M., Tjellesen L., and Mortensen P.B. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium and macronutrients in patients with intestinal resection. Gut 43 6 (1998) 763-769
43. Serfaty-Lacrosniere C., Wood R.J., Voytko D., et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 14 4 (1995) 364-368
44. Dyckner T., and Wester P.O. Intracellular magnesium loss after diuretic administration. Drugs 28 suppl 1 (1984) 161-166